Image
Point-of-Careā„¢ 101

Catching Your Breath in COPD

Guidelines

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2022 report.

Clinical management of COVID-19: living guidance.

World Health Organization. June 2022.

Clinical Practice Tools and Resources

The COPD Foundation Pocket Consultant Guide Mobile App

The COPD Pocket Guide, provided by the COPD Foundation, contains comprehensive management information as well as resource tools. It can be downloaded onto any mobile device.

Modified Medical Research Council (mMRC) Dyspnea Scale

The mMRC scale, provided by MDCalc, allows for the baseline stratification of dyspnea in COPD, as well as other respiratory diseases.

COPD Control Questionnaire (CCQ)

The CCQ measures health status and can be used to assess health-related quality of life (HRQL).

COPD Assessment Test (CAT)

The CAT, provided by the American Academy of Family Physicians, allows assessment of the global impact of COPD (cough, sputum, dyspnea, chest tightness) on patient health status.

COPD Action Plan

The COPD Action Plan, provided by the American Lung Association, is a tool that facilitates the prevention, timely identification, and early and appropriate treatment of COPD exacerbations.

ATS Telemedicine Information Series

The American Thoracic Society offers patients educational materials on telemedicine as well as answers to frequently asked questions surrounding this topic.

Patient Resources and Advocacy Organizations

The COPD Foundation Pocket Consultant Guide Patient-Focused Mobile App

The COPD Pocket Guide for Patients was designed to improve disease management and communication with a patient’s health care team. It includes patient resources such as inhaler and exercise videos as well as tools such as the wallet card and daily symptom tracker that help collect and share information with the health care team. It can be downloaded onto any mobile device.

American Lung Association

The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy, and research.

COPD Foundation

The COPD Foundation’s mission is to prevent and cure COPD and to improve the lives of all people affected by COPD.

Global Initiative for Chronic Obstructive Lung Disease (GOLD)

GOLD partners with health care professionals and public health officials to raise awareness of COPD and to improve prevention and treatment of this lung disease for patients around the world.

National Jewish Health

National Jewish Health integrates the latest scientific discoveries with coordinated care for lung, heart, and immune diseases. Their Patient Education Program provides many free educational opportunities and support groups to assist patients and caregivers with managing illnesses and chronic conditions, such as COPD.

Suggested Readings

GOLD COVID-19 guidance.

Global Initiative for Chronic Obstructive Lung Disease (GOLD).

Protocol summary of the COPD Assessment in Primary care To identify Undiagnosed Respiratory disease and Exacerbation risk (CAPTURE) validation in primary care study.

Yawn BP, et al. Chronic Obstr Pulm Dis. 2021;8(1):60-75.

Reducing chronic obstructive pulmonary disease hospital readmissions. An official American Thoracic Society workshop report.

Press VG, et al. Ann Am Thorac Soc. 2019;16(2):161-170.

Once-daily single-inhaler triple versus dual therapy in patients with COPD.

Lipson DA, et al. N Engl J Med. 2018; 378(18):1671-1680.

The effect of exacerbation history on outcomes in the IMPACT trial.

Halpin DMG, et al. Eur Respir J. 2020;55(5):1901921.

Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD.

Rabe KF, et al. N Engl J Med. 2020;383(1):35-48.

Reduced all-cause mortality in the ETHOS trial of budesonide/glycopyrrolate/formoterol for chronic obstructive pulmonary disease. A randomized, double-blind, multicenter, parallel-group study.

Martinez FJ, et al. Am J Respir Crit Care Med. 2021;203(5):553-564.

PRIMUS - Prompt Initiation of Maintenance Therapy in the US: a real-world analysis of clinical and economic outcomes among patients initiating triple therapy following a COPD exacerbation.

Tkacz J, Evans KA, Touchette DR, et al. Int J Chron Obstruct Pulmon Dis. 2022;17:329-342.

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice.

Halpin DMG, Worsley S, Ismaila AS, et al. ERJ Open Res. 2021;7(2):00950-02020.

Activity
A Review of Current COPD Management Guidelines

Catching Your Breath in COPD - Module 1

Activity
The Evolving Role of Triple Combination Therapy for COPD

Catching Your Breath in COPD - Module 2

Activity
Managing COPD in the Era of COVID-19

Catching Your Breath in COPD - Module 3

Relevant Resources

Chronic Obstructive Pulmonary Disease, Asthma, or Both

Differential Diagnosis and Comprehensive Management Strategies

Improving Outcomes in Chronic Obstructive Pulmonary Disease

Optimizing Maintenance Therapy Across Healthcare Settings

Clearing the Air

Improving Outcomes for Patients with COPD

Comprehensive Management of Chronic Obstructive Pulmonary Disease

Collaborative Approaches to Guideline-Concordant Patient Care

Clinical Updates in the Management of Severe Asthma

New Strategies for Individualizing Long-term Care

Improving Outcomes in Severe Asthma

A New Era in Precision Medicine

Caring for Patients with Severe Asthma

Evolving Best Practices to Optimize Outcomes

Clinical Issues in Severe Asthma

Consensus and Controversies on the Road to Precision Medicine

Breathing Life Into COPD Management

Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care

Clinical Issues in Severe Asthma

Debates and Discussions About Personalizing Patient Management

Advancing the Care of Severe Asthma

Differential Diagnosis, Multidisciplinary Management, and Patient Engagement

Focusing on Patients With Severe Asthma

From Guideline Recommendations to Daily Clinical Decision-Making

Clearing the Air in Severe Asthma Management

Improving Patient Outcomes Through Shared Clinical Decision Making

Clearing the Air in Severe Asthma Management

Improving Patient Outcomes Through Shared Clinical Decision Making

Marching Forward in Atopic Dermatitis

Digging Deep on Shared Decision-Making

Airing It Out

A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis

COPD in Managed Care

The Clinical and Utilization Benefits of Exacerbation Prevention

Finding the Right Path in Severe Asthma

Mechanistic Insights and Emerging Treatment Options

COPD Cases and Conversations

A Focus on Exacerbation Prevention

Demystifying New Evidence for COPD Management

Best Practices for Primary Care

Updates on Chronic Rhinosinusitis with Nasal Polyps

Evolving Best Practices for Patient Management

A Breath of Fresh Air in Pediatric Asthma

Shared Decision-making in the Era of Biologics

Swimming Upstream in Severe Asthma

New Pathways to Patient Management

Where are We Now In Moderate-to-Severe Asthma?

From Comprehensive Patient Evaluations to Individualized Evidence-based Care

COPD Cases & Conversations

Preventing COPD Exacerbations to Improve Outcomes

Comprehensive Management in COPD

A Whole Patient Case Series

Clinical Issues in COVID-19

Debates and Discussions about Monoclonal Antibody Therapies

Minimizing Patient Risks From COVID-19

An Update on Monoclonal Antibody Therapies

Cause for Alarm

New Avenues to the Management of Severe Asthma

Getting Up To Speed In Moderate-To-Severe Asthma

Evolving Best Practices for Pediatric Patients

Finding the Path in Eosinophilic Esophagitis

Interdisciplinary Strategies for Adult and Pediatric Patients

Answering the Call

Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema

Getting Low in Familial Hypercholesterolemia

Reducing LDL-C and a Lifetime of Cardiovascular Risk

Putting a Spotlight on Systemic Mastocytosis

A Multidisciplinary Look at Early Diagnosis and Management

Targeting Clear Horizons

Finding the Path in Chronic Rhinosinusitis with Nasal Polyps

Clinical Updates in COVID-19

Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment

Is It Systemic Mastocytosis?

Best Practices for Diagnosis and Management

Monoclonal Antibodies for COVID-19

An Update on Best Practices

Monoclonal Antibodies for COVID-19

New Avenues to Pre-Exposure Prophylaxis

Answering the Bell in Severe Asthma

New Pathways to Optimize Patient Outcomes

Clinical Issues in Severe Asthma

Debates and Discussions About New Upstream Treatment Avenues

Clearing the Way in Atopic Dermatitis

A Case-Based Update on Pediatric Patients